Zhichao Zhou at Karolinska Institutet - Research Interests, Publications & Academic Profile

Zhichao Zhou

Karolinska Institutet

Sweden

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Continue in dashboard

Contact this professor

ORCID

Google Scholar

Research Interests

Cardiology

100%

Cell Biology

50%

Endothelial Function

90%

Circulatory Physiology

40%

Vascular Biology

40%

Diabetology

40%

Cardiovascular Biology

30%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles20

Differences in endothelial function between patients with Type 1 and Type 2 diabetes: effects of red blood cells and arginase.

Article Link

Year:

2024

Circular RNA regulatory role in pathological cardiac remodelling.

Article Link

Year:

2024

Purinergic P2X3 receptors in the carotid body as new therapeutic targets for controlling heart failure

Article Link

Year:

2024

Erythrocyte-Derived microRNAs: Emerging Players in Cardiovascular and Metabolic Disease

Article Link

Year:

2023

Stimulation of Erythrocyte Soluble Guanylyl Cyclase Induces cGMP Export and Cardioprotection in Type 2 Diabetes.

Article Link

Year:

2023

Extracellular vesicles and their non‐coding RNA cargos: Emerging players in cardiovascular disease

Article Link

Year:

2023

Hypoxic erythrocytes mediate cardioprotection through activation of soluble guanylate cyclase and release of cyclic GMP.

Article Link

Year:

2023

The long noncoding RNA THBS1-AS1 promotes cardiac fibroblast activation in cardiac fibrosis by regulating TGFBR1.

Article Link

Year:

2023

Inhibition of long noncoding RNA Gm41724 alleviates pressure overload-induced cardiac fibrosis by regulating lamina-associated polypeptide 2α.

Article Link

Year:

2023

Red Cell Distribution Width Is Independently Associated with Mortality in Sepsis

Article Link

Year:

2022

Downregulation of Erythrocyte miR-210 Induces Endothelial Dysfunction in Type 2 Diabetes

Article Link

Year:

2022

The red blood cell as a mediator of endothelial dysfunction in patients with familial hypercholesterolemia and dyslipidemia.

Article Link

Year:

2022

Purinergic activation in response to hemodynamic force directs heart valve development

Article Link

Year:

2022

Therapeutic Potential of Sunitinib in Ameliorating Endothelial Dysfunction in Type 2 Diabetic Rats

Article Link

Year:

2022

MicroRNA: A mediator of diet-induced cardiovascular protection

Article Link

Year:

2021

Adenosine and adenosine receptor-mediated action in coronary microcirculation

Article Link

Year:

2021

Purinergic interplay between erythrocytes and platelets in diabetes-associated vascular dysfunction

Article Link

Year:

2021

Infective endocarditis – A review of current therapy and future challenges

Article Link

Year:

2021

Ticagrelor: a cardiometabolic drug targeting erythrocyte-mediated purinergic signaling?

Article Link

Year:

2021

More purinergic receptors deserve attention as therapeutic targets for the treatment of cardiovascular disease

Article Link

Year:

2020

Collaborators7

John Pernow

Karolinska Institutet

SWEDEN

View Details

Oskar Kovamees

Karolinska Institutet

SWEDEN

View Details

Jon Lundberg

Professor

Karolinska Institutet

SWEDEN

View Details

Jonas Brinck

Associate Professor

Karolinska Institutet

SWEDEN

View Details

Venet Osmani

Associate Professor

University of Sheffield

UNITED KINGDOM

View Details

Aida Collado

Karolinska Institutet

SWEDEN

View Details

Malin Levin

Professor, Head of department

University of Gothenburg

SWEDEN

View Details

How do I reach out?

Continue in dashboard